secwatch / observer
8-K filed January 12, 2026, 6:59 PM ET ticker NHP CIK 0001561032
other material confidence high sentiment neutral materiality 0.65

National Healthcare Properties declassifies board, elects Scott Humphrey as director

National Healthcare Properties, Inc.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001561032-26-000005
form_type
8-K
ticker
NHP
cik
0001561032
company_name
National Healthcare Properties, Inc.
filed_at
2026-01-12T23:59:59+00:00
discovered_at
2026-05-14T18:02:35.436671+00:00
generated_at
2026-05-16T10:51:53.428059+00:00
sec_items
["1.01", "3.03", "5.02", "8.01", "5.03", "7.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.65
calibrated_materiality_score
0.65
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001561032-26-000005
json_url
https://secwatch.observer/filing/0001561032-26-000005.json
markdown_url
https://secwatch.observer/filing/0001561032-26-000005.md
text_url
https://secwatch.observer/filing/0001561032-26-000005.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1561032/000156103226000005/0001561032-26-000005-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1561032/000156103226000005/hct-20260109.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

cb7bf9e5579aa69da838e701a55b9f54b5b87438

National Healthcare Properties, Inc.: Board amended and restated bylaws to implement universal proxy rules, enhance stockholder nomination procedures, provide proxy access, and remove director qualification provision (effective 2026-01-09).

On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

eb6b593ba7cf0a088095ba8ffa947b8c274bf095

National Healthcare Properties, Inc.: Company filed Articles Supplementary to effect declassification of the Board and prohibit election to be subject to MUTA Section 3-803 without stockholder approval (effective 2026-01-12).

On January 12, 2026, the Company filed one set of Articles Supplementary with the SDAT to document and effect the Declassification Election (the “Declassification Articles Supplementary”), and a separate set of Articles Supplementary to effect the Prohibition (the “Prohibition Articles Supplementary”), in each case effective immediately upon acceptance for record of such filings by the SDAT.

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

fa7ccb678f93b95db1548aa0ffc9494fab234781

National Healthcare Properties, Inc. amended Rights Agreement Amendment with Computershare Trust Company, N.A. (effective 2026-01-09).

On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

DGAC

Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE

DISCIPLINED GROWTH ACQUISITION Corp June 1, 2026, 4:15 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19

Comparable filing

On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.

Filing page SEC filing

SAGU

Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE

Shreya Acquisition Group May 11, 2026, 7:59 PM ET other_material Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.02, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19

Comparable filing

On May 6, 2026, and in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association.

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19

Comparable filing

On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.

Filing page SEC filing

PBT

Court approves trust indenture amendments eliminating 75% supermajority requirement

PERMIAN BASIN ROYALTY TRUST May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 3.03, 5.03, 7.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.

Comparable filing

Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.

Filing page SEC filing

PSEC

Prospect Capital enters $400M at-the-market preferred stock offering; reclassifies 16M common shares

PROSPECT CAPITAL CORP May 8, 2026, 7:59 PM ET other_material Items 1.01, 3.03, 5.03, 9.01

same fact type: governance_change, material_agreement same SEC item: 1.01, 3.03, 5.03, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Board amended and restated the Company’s amended and restated bylaws, effective immediately (as so amended and restated, the “Amended and Restated Bylaws”), to, among other things: • address the “universal proxy rules” adopted by the SEC pursuant to Rule 14a-19

Comparable filing

On May 8, 2026, in connection with the Offering, the Company filed Articles Supplementary (the “Articles Supplementary”) with the State Department of Assessments and Taxation of Maryland (“SDAT”), reclassifying and designating 16,000,000 authorized and unissued shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), into shares of Series A Preferred Stock.

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 7.01, 8.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.

Comparable filing

On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).

Filing page SEC filing

VTIX

Virtuix amends warrants to $4.00 exercise price, extends period to July 27, 2026

Virtuix Holdings Inc. June 2, 2026, 9:15 AM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.

Comparable filing

On June 1, 2026, Virtuix Holdings Inc. (the “Company”) entered into amendments to each of the following warrants to purchase shares of Class A Common Stock (collectively, the “Warrant Amendments”) with Streeterville Capital, LLC (the “Investor”) amending the exercise price and extending the Reduced Exercise Price Period (as defined below) to each such warrant

Filing page SEC filing

BJDX

Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing

Bluejay Diagnostics, Inc. June 2, 2026, 6:30 AM ET other_material Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01, 7.01, 9.01 same event type: other_material similar materiality

This filing

On January 9, 2026, the Company entered into Amendment No. 2 (the “Rights Agreement Amendment”) to its Rights Agreement solely to accelerate the expiration date of the Rights from May 18, 2026 to January 12, 2026.

Comparable filing

On May 27, 2026, Bluejay Diagnostics, Inc. (the “Company”) entered into an agreement and statement of work (together, the “Agreement”) with Argonaut Manufacturing Services c/o Argonaut, Inc. (“Argonaut”) regarding the provision by Argonaut to the Company of certain manufacturing services to support the Company’s SymphonyTM platform.

Filing page SEC filing

Source: SEC EDGAR
accession 0001561032-26-000005

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.